Marta Cudzik | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Dr. Marta Cudzik | Medicine and Health Sciences | Research Excellence Award

Institute of Psychiatry and Neurology | Poland

Dr. Marta Cudzik is a psychiatry-focused physician–researcher whose scholarly work lies at the intersection of neuroscience, emotional processing, and obesity-related mental health disorders. Her research examines how affective regulation, emotional intelligence, and trauma-related psychological mechanisms influence vulnerability to depression and other psychiatric conditions. She has authored peer-reviewed studies addressing emotional dysregulation, dissociative defense mechanisms in childhood trauma, and alexithymia among individuals with obesity, contributing clinically relevant insights to contemporary psychiatric research. A central theme of her work is the integration of psychological, neurobiological, and metabolic perspectives to better understand complex mind–body interactions. Dr. Marta Cudzik is developing an emerging interdisciplinary research direction referred to as psycho-obesitology, which seeks to bridge psychiatry and metabolic medicine through evidence-based frameworks. Her research aims to support more holistic diagnostic and therapeutic strategies in mental health, with implications for prevention, personalized treatment, and translational psychiatric care.

Profile: ORCID

Featured Publications

Cudzik, M., Lis, M., Wichniak, A., & Bieńkowski, P. (2026). Alexithymia among patients with obesity: A systematic review. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2025.12.030

Cudzik, M., Soroka, E., & Olajossy, M. (2019). The impact of emotional intelligence level on depression vulnerability. Current Problems of Psychiatry, 20(3). https://doi.org/10.2478/cpp-2019-0011

Cudzik, M., Soroka, E., & Olajossy, M. (2019). Dissociative identity disorder as a wide range of defense mechanisms in children with a history of early childhood trauma. Current Problems of Psychiatry, 20(2). https://doi.org/10.2478/cpp-2019-0006

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Published on by Forensic Scientist

Ms. Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Lecturer-Researcher | Rey Juan Carlos University | Spain

Silvia Di Bonaventura is a passionate researcher, professor, and social entrepreneur with a commitment to advancing scientific innovation. Her journey reflects an insatiable curiosity, strong leadership, and dedication to contributing to transformative projects in health and biomedicine. Fluent in five languages, she combines global perspectives with academic rigor and entrepreneurial vision to address complex challenges in research and healthcare.

Profile:

Strengths for the Awards:

  1. Academic Excellence:
    Silvia’s strong academic foundation includes degrees in Physiotherapy, Invasive Physiotherapy, and an ongoing PhD in Pain Research, coupled with a Master’s in Clinical Research at Harvard University, showcasing her commitment to scientific rigor and innovation.
  2. Research Contributions:
    Silvia has demonstrated significant contributions to pain research, with notable publications on neuromodulation and digital health interventions for chronic pain. Her work combines clinical relevance and innovative methodologies, emphasizing her potential to make lasting impacts in biomedicine.
  3. Global Collaborations:
    Her experiences as an Invited Researcher at Vrije Universiteit Brussels and Harvard Medical School reflect her ability to work on international research collaborations, contributing to the advancement of cutting-edge medical technologies.
  4. Entrepreneurial Leadership:
    As the CEO of Bei (a digital health app for fibromyalgia) and the Founder of PainCorp, Silvia has effectively bridged research with practical healthcare solutions, emphasizing her visionary approach and ability to create real-world impact.
  5. Awards and Recognitions:
    Silvia’s accolades, including the Banco Santander Scholarship, Young Emerging Leader 2022, and the Outstanding Leadership Award, highlight her dedication, leadership, and exceptional achievements in the field.
  6. Multilingual Communication Skills:
    Fluent in five languages, Silvia has the ability to collaborate and communicate effectively across diverse cultures, enhancing her research’s global reach and impact.

🎓Education 

  • Diploma in Computer Science (2009–2014)
    Instituto Técnico Industrial “IIS” – TE
  • Degree in Physiotherapy (2014–2018)
    Universidad Alfonso X El Sabio
  • Master’s Degree in Invasive Physiotherapy (2017–2018)
    Universidad Camilo José Cela
  • Master’s Degree in Clinical Research (2024–2024)
    Harvard University
  • PhD in Pain Research (2021–Present)
    Universidad Rey Juan Carlos

💼Experience 

  • Physiotherapist & Co-Director
    Clínica Gatzambide (2018–2022)
    Led a successful physiotherapy practice focused on personalized patient care.
  • Professor & Researcher
    Rey Juan Carlos University (2021–Present)
    Teaching and conducting groundbreaking research in pain management.
  • Invited Researcher
    Vrije Universiteit Brussels (2023) & Harvard Medical School (2024)
    Advanced research on neuromodulation and pain mechanisms.
  • Entrepreneurial Roles
    • CEO & Founder of Bei (2024–Present): Innovating solutions for fibromyalgia self-management.
    • President of PainCorp (2024–Present): Dedicated to pain research and treatment.
    • Research Fellow at Mit LinQ and Harvard (2024–Present): Driving forward collaborative research initiatives.

🔬Research Interests On Health Sciences

Silvia’s research centers on pain management, clinical research, neuromodulation, and digital health solutions. She is particularly focused on designing innovative interventions for chronic pain conditions such as fibromyalgia, combining scientific rigor with practical applications for patient care.

🏆Awards 

  • Top 15 Graduates in Spain (Physiotherapy Ranking)
  • Banco Santander Scholarship (Best Academic Record)
  • PI in Competitive Funding (Biomedicine Research)
  • Entrepreneurship Babson College Scholarship
  • Nova Talent Member
  • Young Emerging Leader ’22 (Korea World Summit)
  • Outstanding Leadership Award (Harbour Space University)

🥇Achievements & Certifications

  • Recognized as one of the Top 15 Graduates in Spain in Physiotherapy.
  • Awarded Banco Santander Scholarship for academic excellence.
  • Recipient of Babson College Entrepreneurship Scholarship for advancing digital health solutions.
  • Certified in Italian (Native), Spanish (C2), English (C1), French (B1), and Chinese (HSK2).

🌍Final Note

Silvia Di Bonaventura exemplifies a modern researcher blending academic excellence, global collaboration, and entrepreneurship. Through her multifaceted roles, she seeks to bridge the gap between research and real-world impact, paving the way for transformative solutions in healthcare.

Publication Top Note’s

“How Does Conditioned Pain Modulation Influence Motor Imagery Processes in Women with Fibromyalgia Syndrome? A Cross-Sectional Study Secondary Analysis”

  • Authors: Víctor Riquelme-Aguado, Silvia Di-Bonaventura, María Elena González-Álvarez, Alazne Zabarte-Del Campo, Josué Fernández-Carnero, Antonio Gil-Crujera, Francisco Gómez-Esquer, Jorge Hugo Villafañe
  • Journal: Journal of Clinical Medicine
  • Year: 2024

“The Link between Endogenous Pain Modulation Changes and Clinical Improvement in Fibromyalgia Syndrome: A Meta-Regression Analysis”

  • Authors: Kevin Pacheco-Barrios, Rafaela Machado Filardi, Luis Fernando González-González, Nayeon Park, Fernanda Queiroz Petrus, Alba Navarro-Flores, Silvia Di-Bonaventura, Luana Gola Alves, Fernanda Queiroz, Felipe Fregni
  • Journal: Biomedicines
  • Year: 2024

“Perceived Benefits and Limitations of a Psychoeducation Program for Patients with Fibromyalgia: An Interpretative Phenomenological Analysis”

  • Authors: Silvia Di-Bonaventura, Raúl Ferrer-Peña, Joaquín Pardo-Montero, Josué Fernández-Carnero, Roy La Touche
  • Journal: Frontiers in Psychology
  • Year: 2024

“Effectiveness of Biobehavioral Therapeutic Education in Chronic Low Back Pain Intensity and Disability: A Systematic Review”

  • Authors: David Ruíz-del Río, Roy La Touche, Gwendoline Giolito, Silvia Di-Bonaventura, Mónica Grande-Alonso, Álvaro Reina Varona
  • Journal: Journal of MOVE and Therapeutic Science
  • Year: 2024

“Can a Specific Biobehavioral-Based Therapeutic Education Program Lead to Changes in Pain Perception and Brain Plasticity Biomarkers in Chronic Pain Patients? A Study Protocol for a Randomized Clinical Trial”

  • Authors: Silvia Di Bonaventura, Stephen D. Ginsberg, Josué Fernández Carnero, Raúl Ferrer-Peña
  • Journal: PLOS ONE
  • Year: 2024

“Effect of Different Physical Therapy Interventions on Brain-Derived Neurotrophic Factor Levels in Chronic Musculoskeletal Pain Patients: A Systematic Review”

  • Authors: Silvia Di-Bonaventura, Josué Fernández-Carnero, Luis Matesanz-García, Alberto Arribas-Romano, Andrea Polli, Raúl Ferrer-Peña
  • Journal: Life
  • Year: 2023

 

Hyung-Youl Park | Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Hyung-Youl Park | Health Sciences | Best Researcher Award

Assistant Professor | Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea | South Korea 

Dr. Hyung-Youl Park is a Clinical Assistant Professor in the Department of Orthopedic Surgery at Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea. With a focus on spinal cord injuries, disc degeneration, adult spinal deformity, minimally invasive surgery, and osteoporosis, Dr. Park has established himself as a leading figure in both clinical and academic orthopedic surgery. His dedication to improving spinal health is evident in his extensive research, teaching, and clinical expertise.

Profile

Orcid

Strenghts for the Awards

  • Prolific Research Output:
    Dr. Hyung-Youl Park has published extensively, with 72 research articles, including 50 high-impact works in prestigious journals like the European Spine Journal, Diagnostics, World Neurosurgery, and Clinical Orthopaedics and Related Research. His contributions reflect a consistent focus on advancing orthopedic surgery, spinal diseases, and geriatric spinal care.
  • Diverse and Impactful Research Areas:
    His research spans critical topics such as:

    • Risk factors for mechanical complications in spinal surgeries.
    • Pathophysiology and treatment of Kummell’s Disease.
    • Effects of telemedicine on medical staff post-COVID-19.
    • Innovations in bone regeneration and biomaterials.
    • Geriatric spinal fusion and osteoporosis treatment strategies.
    • Surgical management of spinal metastases and deformities.

    These studies showcase clinical relevance and translational impact on improving patient outcomes, particularly in geriatric and oncology-related spinal care.

  • Collaboration and Leadership:
    Dr. Park has co-authored with notable experts like Young-Hoon Kim and Kee-Yong Ha, reflecting his active collaboration in multidisciplinary teams. His involvement in pivotal studies, such as surgical risk factors, spinal imaging, and regenerative medicine, indicates leadership in shaping clinical practices.
  • High-Impact Publications:
    Many of his works are published in journals indexed in Web of Science and Scopus, with notable DOI-linked contributions that enhance global accessibility. His study on telemedicine satisfaction post-pandemic (Telemedicine and e-Health, 2024) and innovative use of recombinant human BMP-2 (Bioengineering, 2023) demonstrate cutting-edge advancements.
  • Clinical Relevance and Recognition:
    Dr. Park’s research addresses real-world challenges, such as post-surgical complications, lumbar stenosis, and adjacent segment degeneration. His findings offer actionable insights for surgical decision-making and patient care optimization.

Education 🎓

Dr. Park holds an impressive academic background:

  • Ph.D. in Orthopedic Surgery (2022), The Catholic University Graduate School, Seoul, Korea.
    • Dissertation: “Are the Choice of Frame and Intraoperative Patient Positioning Associated with Radiologic and Clinical Outcomes in Long-Instrumented Lumbar Fusion for Adult Spinal Deformity?”
  • M.D. (2012), The Catholic University, College of Medicine, Seoul, Korea.

His postgraduate training includes internships, residency, and fellowships at renowned hospitals within the Catholic Medical Center in Korea.

Experience 🏥

Dr. Park’s professional journey spans over a decade of clinical expertise:

  • Clinical Assistant Professor (2020 – Present): Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea.
  • Clinical Fellow (2017–2020): Department of Orthopedic Surgery at Seoul and Eunpyeong St. Mary’s Hospitals.
  • Orthopedic Resident (2013–2017): Seoul St. Mary’s Hospital, Catholic Medical Center, Seoul, Korea.

He actively teaches medical students and residents and has played a pivotal role in weekly spine disorder reviews and conferences.

Research Interests 🔬

Dr. Park’s primary research interests include:

  • Spinal cord injury and disc degeneration.
  • Adult spinal deformity and minimally invasive spine surgery.
  • Osteoporosis and its effects on spinal health.

His research integrates basic science with clinical applications to improve patient outcomes in spine surgery.

Awards and Recognitions 🏆

Dr. Park’s work has earned numerous accolades:

  • Young Investigator Award, Korean Society of Spinal Surgery (2023).
  • Best Investigator Award, Department of Orthopedic Surgery, The Catholic University of Korea (2022).
  • Oral Presentation Awards for innovative research in osteoporosis and spinal tumors at multiple national and international congresses (2016–2021).
  • Nomination for Hibbs Award, Scoliosis Research Society (2017).

These honors reflect his commitment to advancing orthopedic surgery through groundbreaking research.

Publications 📚

Dr. Hyung-Youl Park has authored several impactful articles in high-ranking journals:

  1. “Risk factors for mechanical complications after fusion extension surgery for lumbar adjacent segment disease”
    • Authors: Kim, Young-Hoon; Ha, Kee-Yong; Ahn, Joonghyun; Park, Hyung-Youl; Chang, Dong-Gune; Lim, Jae-Hak; Kim, Sang-Il
    • Journal: European Spine Journal
    • DOI: 10.1007/S00586-023-07880-5
  2. “Understanding Kummell’s Disease: Definition, Diagnosis, Pathophysiology, and Treatment”
    • Authors: Young-Il Ko; Myung-Sup Ko; Chungwon Bang; Hyung-Youl Park; Sang-Il Kim; Young-Hoon Kim
    • Journal: Journal of Korean Society of Spine Surgery
    • DOI: 10.4184/jkss.2024.31.1.23
  3. “Sagittal Realignment Following Decompression for Lumbar Spinal Stenosis in Elderly Patients: A Comprehensive EOS Imaging Analysis”
  4. “Satisfaction Survey of Medical Staff for Telemedicine after the COVID-19 Pandemic”
    • Authors: Seung Eun Jung; Young-Mi Kwon; Soon-Yong Kwon; Young-Hoon Kim; Hyung-Youl Park
    • Journal: Telemedicine and e-Health
    • DOI: 10.1089/tmj.2024.0142
  5. “The Effects of Longer Use of Teriparatide on Clinical and Radiographic Outcomes after Spinal Fusion in Geriatric Patients”
    • Authors: Young-Hoon Kim; Kee-Yong Ha; Hyun W. Bae; Hyung-Youl Park; Young-Il Ko; Myung-Sup Ko; Sang-Il Kim
    • Journal: Medicina
    • DOI: 10.3390/medicina60060946
  1. “Effects of bone cement augmentation for uppermost instrumented vertebra on adjacent disc segment degeneration in lumbar fusions”
    • Authors: Lee, Jae-Won; Kim, Hun-Chul; Kim, Sang-Il; Min, Hyung-Ki; Ha, Kee-Yong; Park, Hyung-Youl; Cho, Chang-Hee; Sung, Hoon-Seok; Lim, Jae-Hak; Kim, Young-Hoon
    • Journal: World Neurosurgery
    • DOI: 10.1016/J.WNEU.2022.11.014
  2. “Junctional Failures at Both Ends After Long Fusion Arthrodesis Stopping at L5: Incidences and Risk Factors”
    • Authors: Kim, Y.-H.; Ha, K.-Y.; Park, H.-Y.; Ko, M.-S.; Ko, Y.-I.; Sin, K.-J.; Kim, S.-I
    • Journal: World Neurosurgery
    • DOI: 10.1016/j.wneu.2023.09.063
  3. “Predictive factors for conversion from conservative to surgical treatment in osteoporotic thoracolumbar compression fractures”
    • Authors: Sung, Hoon-Seok; Kim, Sang-Il; Park, Hyung-Youl; Ko, Myung-Sup; Lee, Jeong-Han; Kim, Young-Hoon
    • Journal: European Spine Journal
    • DOI: 10.1007/S00586-023-07864-5
  4. “Risk Factors for Conversion to Open Spinal Surgery after Percutaneous Epidural Neuroplasty”
    • Authors: Young-Hoon Kim; Sang-Il Kim; Jun-Seok Lee; Hyung-Youl Park
    • Journal: Journal of Korean Society of Spine Surgery
    • DOI: 10.4184/jkss.2023.30.1.18
  5. “When Should Spinal Surgery Be Considered for Spinal Metastasis from Non-Small Cell Lung Cancer?”
    • Authors: Hyung-Youl Park; Kee-Yong Ha; Sang-Il Kim; Yeon-Sil Kim; Yongwon Joh; Young-Hoon Kim
    • Journal: Journal of Clinical Medicine
    • DOI: 10.3390/jcm12144683

Conclusion

Dr. Hyung-Youl Park is a distinguished orthopedic surgeon, educator, and researcher dedicated to advancing spine health through innovative clinical practices and impactful research. His achievements reflect a blend of clinical expertise, academic excellence, and a passion for improving patient outcomes.